EORTC consensus recommendations on the optimal management of colorectal cancer liver metastasesGiacomo Bregni, Markus Moehler, Elena Élez et al.|Cancer Treatment Reviews|2025Cited by 20
Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelinesGiacomo Bregni, Francesco Sclafani, Tuğba Akın Telli et al.|Cancer Treatment Reviews|2019Cited by 19
Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisationZelda Paquier, Maria Antonietta Bali, Shih‐Li Chao et al.|Physica Medica|2022Cited by 13
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup AnalysisGerardo Rosati, Fabio Galli, Maurizio Cantore et al.|The Oncologist|2020Cited by 11
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancerGiacomo Bregni, Francesco Sclafani, Caroline Vandeputte et al.|Acta Oncologica|2021Cited by 11